Updated: July 12, 2026
Funding raised
520000000
About the program
Program type
Investment stage
Investment focus areas
Description
Paris and SF-based growth investor backing commercial-stage European healthtech companies expanding into the US. €20M–€50M checks, minority and majority. Anchored by Bpifrance, EIF, Morgan Stanley IM.